UBS Group AG

Holdings History for Prime Medicine, Inc. - COMMON STOCK (PRME)

Symbol: PRME on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$8,468,823	2,440,583	+2,135,810	+701%	$3.47	Q4 2025
30 Sep 2025	0%	+0%	$1,688,443	304,773	+109,446	+56%	$5.54	Q3 2025
30 Jun 2025	0%	+0%	$482,458	195,327	+77,647	+66%	$2.47	Q2 2025
31 Mar 2025	0%	-0%	$234,183	117,680	-100,506		$1.99	Q1 2025
31 Dec 2024	0%	+0%	$637,104	218,186	+183,165	+523%	$2.92	Q4 2024
30 Sep 2024	0%	+0%	$135,532	35,021	+12,482	+55%	$3.87	Q3 2024
30 Jun 2024	0%	-0%	$115,850	22,539	-19,984	-47%	$5.14	Q2 2024
31 Mar 2024	0%	+0%	$297,661	42,523	+11,111	+35%	$7.00	Q1 2024
31 Dec 2023	0%	-0%	$278,310	31,412	-12,360	-28%	$8.86	Q4 2023
30 Sep 2023	0%	-0%	$417,585	43,772	-55,267	-56%	$9.54	Q3 2023
30 Jun 2023	0%	+0%	$1,450,921	99,039	+94,104	+1907%	$14.65	Q2 2023
31 Mar 2023	0%	+0%	$60,701	4,935	+3,726	+308%	$12.30	Q1 2023
31 Dec 2022	0%	+0%	$22,463	1,209	+1,209	NEW	$18.58	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.